Signaling in primary thymocytes after presentation of altered peptide ligands by antigen-presenting cells or MHC-peptide tetramers.
Smyth
L A
LA
Divisions of Molecular Immunology, National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA.
Reynolds
L
L
Tyrrell
R
R
Williams
O
O
Norton
T
T
Schumacher
T
T
Tybulewicz
V
V
Ley
S C
SC
Kioussis
D
D
D000595:Amino Acid Sequence; D000818:Animals; D017951:Antigen Presentation; D000938:Antigen-Presenting Cells / Q000276:immunology / Q000378:metabolism; D004789:Enzyme Activation; D006183:H-2 Antigens / Q000737:chemistry / Q000378:metabolism; D007700:Kinetics; D008024:Ligands; D051379:Mice; D008822:Mice, Transgenic; D019950:Mitogen-Activated Protein Kinase 1 / Q000378:metabolism; D048052:Mitogen-Activated Protein Kinase 3; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D008954:Models, Biological; D010455:Peptides / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D020836:Protein Structure, Quaternary; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism*
D006183:H-2 Antigens; D008024:Ligands; D010455:Peptides; D011505:Protein-Tyrosine Kinases; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; D020928:Mitogen-Activated Protein Kinases